Información del producto
LGD 3303 is a selective estrogen receptor modulator that has been shown to have therapeutic potential for the treatment of metabolic disorders and cancer. LGD 3303 binds to the estrogen receptor alpha (ERα) and beta (ERβ), which has been shown to inhibit the proliferation of human breast cancer cells in vitro. It also inhibits adipose tissue growth, increases bone growth, and improves blood pressure regulation. LGD 3303 has been shown to have beneficial effects on metabolic disorders such as insulin resistance, obesity, and diabetes. This drug may also be able to treat inflammatory diseases such as arthritis or skin conditions like atopic dermatitis in animals.
Propiedades químicas
Consulta técnica sobre: 3D-FL102146 LGD 3303
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
